What's in Taiwan Otsuka Pharm. Co., Ltd's pipeline?

Taiwan Otsuka Pharm. Co., Ltd has 3 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Taiwan Otsuka Pharm. Co., Ltd's portfolio?

Top competitors by shared drug class: Amphastar Pharmaceuticals, Inc., AstraZeneca, Oregon Health and Science University, Sumitomo Pharma America, Inc., Teva Branded Pharmaceutical Products R&D, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/taiwan-otsuka-pharm-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Taiwan Otsuka Pharm. Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Taiwan Otsuka Pharm. Co., Ltd pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Meptin® Swinghaler	Meptin® Swinghaler	phase 3	Beta-2 adrenergic agonist (short-acting or long-acting bronchodilator)	Beta-2 adrenergic receptor	Respiratory / Pulmonology
Berotec	Berotec	phase 3			Other
Ventolin® MDI	Ventolin® MDI	phase 3	Beta-2 adrenergic agonist (short-acting bronchodilator)	Beta-2 adrenergic receptor	Respiratory / Pulmonology

Therapeutic area mix

Respiratory / Pulmonology · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Amphastar Pharmaceuticals, Inc. · 1 shared drug class
AstraZeneca · 1 shared drug class
Oregon Health and Science University · 1 shared drug class
Sumitomo Pharma America, Inc. · 1 shared drug class
Teva Branded Pharmaceutical Products R&D, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Taiwan Otsuka Pharm. Co., Ltd:

Cite this brief

Drug Landscape (2026). Taiwan Otsuka Pharm. Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/taiwan-otsuka-pharm-co-ltd. Accessed 2026-05-16.